Organometallics
Article
35.04 (d, J = 6.4 Hz), 33.62 (d, J = 6.1 Hz), 29.36 (d, J = 43.6 Hz),
28.40 (d, J = 3.6 Hz), 28.04 (d, J = 45.8 Hz), 27.57 (d, J = 37.3 Hz),
27.03 (d, J = 3.8 Hz), 25.87 (d, J = 13.4 Hz), 25.72 (d, J = 13.4 Hz),
25.15 (d, J = 1.4 Hz), 16.48 (d, J = 2.0 Hz), 13.09 (d, J = 1.9 Hz).
31P{1H} NMR (162 MHz, CDCl3, δ): 42.50. IR (ATR, cm−1): 3627,
3558, 2936, 2860, 1633, 1451, 1389, 1283, 1053, 908. HRMS (ESI):
The filtrate was added dropwise to a vigorously stirred solution of
K2PdCl4 (65 mg, 0.2 mmol) in degassed H2O (1.5 mL) at 23 °C. After
the mixture was stirred for 30 min, the brown-yellow precipitate was
collected on a filter, washed successively with H2O (2 × 0.5 mL) and
MeOH (2 × 0.2 mL), and dried in vacuo. In order to remove any Pd
metal, the obtained powder was dissolved in DCM (1 mL) and filtered
through Celite. The filtrate was evaporated with EtOH in vacuo,
yielding pure Pd complex.
20
calcd for [M − BF4]+ 199.1610, found 199.1609. [α]D = −9.3° (c =
0.5, MeCN). Mp: 65−66 °C.
Complex 9a. Prepared from 6a·HBF4 (109 mg). Yield: 48 mg
(55%), light yellow needles. 1H NMR (400 MHz, CDCl3;
predominantly the trans isomer, δ): 3.20−3.33 (m, 2H), 2.26−2.37
(m, 2H), 2.07−2.23 (m, 4H), 1.61−1.76 (m, 3H), 1.46−1.57 (m,
13H), 1.25 (dd, J1 = 15.6 Hz, J2 = 7.1 Hz, 6H). 31P{1H} NMR (162
MHz, CDCl3, δ): 45.8 (trans), 28.8 (cis). IR (ATR, cm−1): 2953,
2929, 2862, 1452, 1408, 1377, 1286, 1162, 1076, 1059, 1014, 886,
739.32. Anal. Found (calcd) for C14H30Cl2P2Pd: C, 38.46 (38.42); H,
(2S,5S)-1-(tert-Butyl)-2,5-dimethylphospholan-1-ium Tetrafluor-
oborate (6e·HBF4). Prepared from 2 M (Et2O) tBuMgCl (1.2 mL).
Recrystallized from a minimum amount of boiling EtOH (ca. 1 mL),
after cooling to 0 °C. Yield: 282 mg (54%), white solid. 1H NMR (400
MHz, CD3CN, δ): 5.68 (dm, JPH = 468.7 Hz, 1H), 2.95−3.10 (m,
1H), 2.75−2.90 (m, 1H), 2.24−2.42 (m, 2H), 1.54−1.73 (m, 2H),
1.49 (dd, J1 = 13.5 Hz, J2 = 7.2 Hz, 3H), 1.45 (dd, J1 = 15.2 Hz, J2 =
7.2 Hz, 3H), 1.43 (d, J = 17.1 Hz, 9H). 13C{1H} NMR (100 MHz,
CD3CN, δ): 36.06 (d, J = 6.8 Hz), 33.90 (d, J = 4.8 Hz), 32.51 (d, J =
40.0 Hz), 31.23 (d, J = 36.1 Hz), 29.04 (d, J = 44.6 Hz), 26.12, 17.22
(d, J = 2.9 Hz), 13.48 (d, J = 2.6 Hz). 31P{1H} NMR (162 MHz,
CD3CN, δ): 49.7. IR (ATR, cm−1): 3631, 2972, 1626, 1465, 1408,
1377, 1283, 1203, 1051, 932, 895, 813, 763, 678, 665. HRMS (ESI):
20
6.97 (6.91). [α]D = +134.6° (c = 0.5, CHCl3). Mp: 164−166 °C.
Assignment of the trans/cis isomers of the complex 9a by 31P spectra
in different solvents: 31P{1H} NMR (162 MHz, C6D6, δ) 28.6 (cis
isomer, one peak only, sample is sparingly soluble); 31P{1H} NMR
(162 MHz, CDCl3, δ) 45.8 and 28.8 (trans:cis ratio 92:8); 31P{1H}
(162 MHz, CD3CN, δ) 47.1 and 29.2 (trans:cis ratio: 83:17).
Complex 9b. Prepared from 6c·HBF4 (123 mg). Yield: 67 mg
(68%), bright yellow solid. 1H NMR (400 MHz, CDCl3, δ): 2.98−3.13
(m, 2H), 2.36−2.53 (m, 4H), 1.98−2.15 (m, 4H), 1.28−1.62 (m,
28H). 31P{1H} NMR (162 MHz, CDCl3, δ): 44.7. IR (ATR, cm−1):
2954, 2939, 2922, 2865, 1454, 1387, 1368, 1246, 1158, 1086, 1059,
1039, 883. Anal. Found (calcd) for C18H38Cl2P2Pd: C, 43.54 (43.78);
H, 7.67 (7.76). [α]D20 = +174.6° (c = 0.5, CHCl3). Mp: 152−153 °C.
Complex 9c. Prepared from 6d·HBF4 (143 mg). Yield: 86 mg
(82%), bright yellow solid. 1H NMR (400 MHz, CDCl3, δ): 2.94−3.07
(m, 2H), 2.44−2.56 (m, 2H), 1.95−2.23 (m, 10H), 1.64−1.91 (m,
10H), 1.18−1.61 (m, 22H). 31P{1H} NMR (162 MHz, CDCl3, δ):
41.1. IR (ATR, cm−1): 2926, 2852, 1447, 1374, 1174, 1159, 1076,
1003, 849, 733. Anal. Found (calcd) for C24H46Cl2P2Pd: C, 50.22
(50.23); H, 8.06 (8.08). [α]D20 = +106.5° (c = 0.5, CHCl3). Mp: 123−
124 °C.
20
calcd for [M − BF4]+ 173.1454, found 173.1454. [α]D = −5.3° (c =
0.3, MeCN). Mp: 199−204 °C.
(2R,5R)-1-Cyclohexyl-2,5-diisopropylphospholan-1-ium Tetra-
fluoroborate (8·HBF4). Cyclohexylphosphine (28.4 mg, 0.25 mmol)
was weighed into a glovebox into a flame-dried reaction tube, dissolved
in THF (1 mL), and cooled to −78 °C. A 1.6 M solution (hexane) of
BuLi (0.23 mL, 0.37 mmol) was added dropwise, and the solution was
warmed to 23 °C and stirred for 1 h. The reaction mixture was cooled
to −78 °C, and a solution of (4S,7S)-4,7-diisopropyl-1,3,2-
dioxathiepane 2,2-dioxide (59.1 mg, 0.25 mmol) in THF (0.5 mL)
was added dropwise. The reaction mixture was warmed to 23 °C,
stirred for 4 h, and cooled to −78 °C. A 1.6 M solution (hexane) of
BuLi (0.23 mL, 0.37 mmol) was added dropwise, and then the
reaction mixture was slowly warmed to 23 °C and stirred overnight. A
1 M (THF) BH3·THF (0.750 mL, 0.750 mmol) was added at 0 °C,
and the reaction mixture was stirred for 1 h at room temperature.
Then 1 M HCl was added at 0 °C. The reaction mixture was diluted
with pentane. The layers were separated, and the organic layer was
further washed with water (×x2) and dried over MgSO4. The crude
mixture was purified by chromatography on silica gel column using
hexane/Et2O 30/1 as eluent to afford BH3-protected (2R,5R)-1-
cyclohexyl-2,5-diisopropylphospholane (40.2 mg,0.15 mmol, 61%
yield) as a colorless oil. This oil was dissolved under nitrogen in 4.0
mL of dry and degassed DCM and cooled to 0 °C, and
diethyloxonium tetrafluoroborate (0.31 mL, 2.24 mmol) was added
dropwise. The reaction mixture was stirred at 0 °C for 30 min and
then 30 min at 23 °C. Degassed 8.0 M hydrogen tetrafluoroborate
(1.90 mL, 14.9 mmol) was added at 23 °C, and the reaction mixture
was vigorously stirred for 30 min. The aqueous phase was washed with
DCM (3 × 10 mL). The combined organic layers were dried over
MgSO4, and DCM was removed in vacuo to afford 8·HBF4 as a white
Complex 9d. Prepared from 6e·HBF4 (130 mg). Yield: 85 mg
(74%), deep yellow solid. 1H NMR (400 MHz, CDCl3, δ): 3.06−3.18
(m, 2H), 2.42−2.53 (m, 2H), 1.98−2.15 (m, 4H), 1.51−1.65 (m,
17H), 1.42−1.48 (m, 17H). 31P{1H} NMR (162 MHz, CDCl3, δ):
48.4; IR (ATR, cm−1): 2991, 2948, 2928, 2894, 2865, 1461, 1451,
1365, 1182, 1157, 1072, 1016, 813.41. Anal. Found (calcd) for
C20H42Cl2P2Pd: C, 45.95 (46.03); H, 8.21 (8.11). [α]D20 = +116.0° (c
= 0.5, CHCl3). Mp: 241−243 °C.
Synthesis of the Nickel Complexes 10. 6a·HBF4 (218 mg, 1
mmol) and powdered Na2CO3 (212 mg, 2 mmol) were suspended in
EtOH (1 mL). The mixture was sonicated at 23 °C for 30 min and
filtered in the glovebox. NiCl2·DME (88 mg, 0.4 mmol) was dissolved
with heating in EtOH (1 mL). The slightly turbid solution was filtered
through Celite and added dropwise to the vigorously stirred solution
of the phosphine. The resulting deep purple solution was refluxed for
15 min, cooled to 23 °C, and concentrated to a volume of ca. 0.5 mL.
After standing at 23 °C overnight the mother liquor was removed and
the residual deep purple crystalline solid was washed successively with
cold MeOH (2 × 0.3 mL) and Et2O (2 × 0.3 mL) and dried in vacuo.
1
solid (50.1 mg, 0.15 mmol, 98% yield). H NMR (400 MHz, CDCl3,
δ): 6.51 (d, JPH = 486.7 Hz, 1H), 2.86−2.69 (m, 1H), 2.59−2.32 (m,
4H), 2.28−2.08 (m, 2H), 2.06−1.68 (m, 6H), 1.62−1.38 (m, 5H),
1.35−1.27 (m, 1H), 1.26 (d, J = 6.6 Hz, 3H), 1.14 (d, J = 6.8 Hz, 3H),
1.12 (d, J = 6.8 Hz, 3H), 1.09 (d, J = 6.6 Hz, 3H). 13C{1H} NMR (100
MHz, CDCl3, δ): 44.3 (d, J = 41.5 Hz), 40.2 (d, J = 44.6 Hz), 31.3 (d,
J = 7.8 Hz), 30.2 (d, J = 1.8 Hz), 30.0 (d, J = 5.1 Hz), 28.5 (d, J = 37.5
Hz), 28.5 (d, J = 3.6 Hz), 28.0 (d, J = 3.8 Hz), 27.5 (d, J = 1.7 Hz),
26.3 (d, J = 13.5 Hz), 25.9 (d, J = 12.9 Hz), 25.0 (d, J = 1.7 Hz), 24.0
(d, J = 2.7 Hz), 23.6 (d, J = 5.2 Hz), 21.7 (d, J = 12.1 Hz), 20.9 (d, J =
10.8 Hz). 31P{1H} NMR (162 MHz, CDCl3, δ): 27.0. IR (ATR,
cm−1): 2965, 2938, 2860, 2435, 1449, 1051, 518. HRMS (ESI): calcd
for [M − BF4]+ 255.2236, found 255.2237. [α]D20 = −71.0° (c = 0.35,
CHCl3). Mp: 202−203 °C.
1
Yield: 86 mg (55%). H NMR (400 MHz, C6D6, δ): 2.8−2.94 (m,
2H), 2.04 (d, J = 6.7 Hz, 6H), 1.49−1.71 (m, 6H), 1.14−1.29 (m,
2H), 0.77−1.01 (m, 14H). 31P{1H} NMR (162 MHz, CDCl3, δ): 66.9.
IR (ATR, cm−1): 3369, 2964, 2930, 2862, 1452, 1411, 1376, 1288,
1162, 1075, 1059, 1015, 925, 888, 737. Anal. Found (calcd) for
20
C14H30Cl2P2Ni: C, 43.41 (43.12); H, 8.12 (7.75). [α]D = +60° (c =
0.5, toluene). Mp: 101−102 °C.
Procedure for the Catalytic Reaction with Aryl Bromide 11.
Pd(dba)2 (1.72 mg, 3.00 μmol), 6e·HBF4 (1.87 mg, 12.0 μmol), 11
(20.8 mg, 0.06 mmol), PivOH (1.84 mg, 18.0 μmol), and Cs2CO3
(29.3 mg, 0.09 mmol) were weighed into a vial equipped with a
magnetic stirrer bar and sealed with a rubber septum. The vial was put
under vacuum and then backfilled with nitrogen (×3). Mesitylene
(200 μL, 0.3 M) was added, and the mixture was degassed by three
General Procedure for the Synthesis of the Palladium
Complexes.25 Phosphine salt 6·HBF4 (0.5 mmol) and powdered
Na2CO3 (106 mg, 1 mmol) were suspended in MeOH (1.5 mL). The
mixture was sonicated at 23 °C for 30 min and filtered in the glovebox.
E
dx.doi.org/10.1021/om3008772 | Organometallics XXXX, XXX, XXX−XXX